Prospects for clinical use of agents acting on ATP receptors - P2-purinoreceptors
- Authors: Ziganshin A.U.1,2, Ziganshina L.E.1,2
-
Affiliations:
- Kazan State Medical University
- University of London College, UK
- Issue: Vol 77, No 2 (1996)
- Pages: 134-136
- Section: Reviews
- URL: https://journal-vniispk.ru/kazanmedj/article/view/104293
- DOI: https://doi.org/10.17816/kazmj104293
- ID: 104293
Cite item
Full Text
Abstract
In addition to the well-known role of purine compounds in cell metabolism, growth, and reproduction, extensive factual material has been accumulated over the past two decades, demonstrating the important role of purines in intercellular interactions. It has been established that a number of physiological and pathophysiological reactions lead to the release of purine compounds (mainly adenosine and adenosine-5'-triphosphoric acid-ATP) by cells, which can interact with special receptors for them, purine receptors. The latter are subdivided into two main classes: PPpurinoreceptors and P2-purinoreceptors, whose main endogenous ligands are adenosine and ATP, respectively.
Keywords
Full Text
##article.viewOnOriginalSite##About the authors
A. U. Ziganshin
Kazan State Medical University; University of London College, UK
Author for correspondence.
Email: info@eco-vector.com
Russian Federation, Kazan; London
L. E. Ziganshina
Kazan State Medical University; University of London College, UK
Email: info@eco-vector.com
Russian Federation, Kazan; London
References
Supplementary files
